Intensive Insulin Glulisine Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Basal Insulin and Oral Glucose-lowering Drugs

Clinical trial NCT01203111 · COMPLETED

Trial details

NCT number: NCT01203111
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2010-12-01
Primary completion: 2012-07-01
Enrollment: 207

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.